Drug Cost Blame Game: Payers’ Contribution To Prices Getting More Attention
Executive Summary
Lawsuit accuses UnitedHealth of elevating member copays in order to recoup the spread between cost sharing and the amount pharmacies pay for a drug.
You may also be interested in...
Drug Pricing: PhRMA Report Aims To Shift Focus To Supply Chain
More than one-third of gross sales for brands is eaten up by rebates, discounts and fees, a study finds, raising questions about whether price concessions provided to payers are ‘flowing to patients,’ PhRMA President Stephen Ubl says.
EpiPen Price Story Highlights Growing Impact Of Drug Deductibles
Nearly half of employer-sponsored insurance plans surveyed require members to meet a deductible before coverage for a prescription drug is approved.
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a 20% mandatory price discount in the catastrophic phase.